PetIQ Inc (PETQ)
16.85
-0.02
(-0.12%)
USD |
NASDAQ |
May 02, 12:07
PetIQ Total Return Level: 16.87 for May 1, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 01, 2024 | 16.87 |
April 30, 2024 | 16.32 |
April 29, 2024 | 16.42 |
April 26, 2024 | 16.53 |
April 25, 2024 | 16.32 |
April 24, 2024 | 16.53 |
April 23, 2024 | 16.60 |
April 22, 2024 | 16.51 |
April 19, 2024 | 16.28 |
April 18, 2024 | 16.03 |
April 17, 2024 | 15.93 |
April 16, 2024 | 16.20 |
April 15, 2024 | 16.18 |
April 12, 2024 | 16.46 |
April 11, 2024 | 17.31 |
April 10, 2024 | 17.75 |
April 09, 2024 | 18.16 |
April 08, 2024 | 18.23 |
April 05, 2024 | 18.39 |
April 04, 2024 | 18.56 |
April 03, 2024 | 18.71 |
April 02, 2024 | 18.24 |
April 01, 2024 | 18.49 |
March 28, 2024 | 18.28 |
March 27, 2024 | 17.44 |
Date | Value |
---|---|
March 26, 2024 | 17.79 |
March 25, 2024 | 17.39 |
March 22, 2024 | 17.48 |
March 21, 2024 | 17.60 |
March 20, 2024 | 17.15 |
March 19, 2024 | 17.21 |
March 18, 2024 | 15.56 |
March 15, 2024 | 15.78 |
March 14, 2024 | 15.55 |
March 13, 2024 | 16.57 |
March 12, 2024 | 16.57 |
March 11, 2024 | 16.43 |
March 08, 2024 | 16.32 |
March 07, 2024 | 16.10 |
March 06, 2024 | 16.18 |
March 05, 2024 | 16.57 |
March 04, 2024 | 16.78 |
March 01, 2024 | 17.37 |
February 29, 2024 | 18.21 |
February 28, 2024 | 18.32 |
February 27, 2024 | 18.67 |
February 26, 2024 | 18.33 |
February 23, 2024 | 18.28 |
February 22, 2024 | 17.68 |
February 21, 2024 | 17.87 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
6.82
Minimum
Oct 10 2022
45.35
Maximum
Apr 27 2021
23.58
Average
23.14
Median
Dec 27 2021
Total Return Level Benchmarks
Dynavax Technologies Corp | 11.68 |
Pacira BioSciences Inc | 26.95 |
Supernus Pharmaceuticals Inc | 30.06 |
Esperion Therapeutics Inc | 2.04 |
Deciphera Pharmaceuticals Inc | 25.36 |